Clinical Trial Update: A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating SPM 962 in advanced Parkinson's disease, comparing against placebo and ropinirole, has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SPM 962

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-05-23